Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

Immunotherapy Advances

Oxford University Press

United KingdomImmunology (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
20H-index (SCImago 2025)
1.504SJR (2025)
2021-2026Coverage

About Immunotherapy Advances

Immunotherapy Advances is a scholarly journal published by Oxford University Press. SCImago 2025 lists it in Q1, with an SJR of 1.504 and H-index of 20.

Coverage: 2021-2026. Research categories: Immunology (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-03. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 2205 GBP
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationPortico
Reported submission-to-publication time7 weeks on average; not a guarantee
Openly licensed content since2021 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2732-4303
ISSN-L2732-4303
Source typeJournal
Publisher / hosting organisationOxford University Press
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex162
Citations recorded in OpenAlex1,876
OpenAlex H-index26
Years represented in OpenAlex2020–2026 (not the founding or closing dates)

Topics in published research

Immunotherapy and Immune Responses; CAR-T cell therapy research; Immune Cell Function and Interaction; Cancer Immunotherapy and Biomarkers; T-cell and B-cell Immunology; Monoclonal and Polyclonal Antibodies Research.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit